Literature DB >> 23046445

Latex C-serum from Hevea brasiliensis induces non-apoptotic cell death in hepatocellular carcinoma cell line (HepG2).

K L Lam1, K L Yang, E Sunderasan, M T Ong.   

Abstract

OBJECTIVES: Latex from Hevea brasiliensis (natural rubber tree primarily cultivated for its rubber particles) has no known primary metabolic function, although its biological role is as a plant defence system. The present study has evaluated specific anti-proliferative effects of latex whole C-serum and its subfractions, on human cancer cell lines.
MATERIALS AND METHODS: Cell viability assay using MTT, DNA fragmentation assay and real-time PCR were used to evaluate the cytotoxic effects of latex whole C-serum and its subfractions on the cell lines.
RESULTS: MTT assay revealed very low LC(50) values, 2.0 and 280 ng/ml, for DCS and DCP treatments, respectively. DCS was proven to be more potent compared to DCP, in conferring specific anti-proliferative effects on the cancer cell lines. The study also indicated that anti-proliferative activity of pre-heated C-serum fractions diminished significantly.
CONCLUSION: Although noteworthy cell death was reported, DNA fragmentation assay and real-time PCR confirmed that that induced by latex C-serum subfractions was not promoted via the classical apoptotic signalling pathway.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23046445      PMCID: PMC6495707          DOI: 10.1111/j.1365-2184.2012.00841.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  15 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Anti-fungal effect of Hevea brasiliensis latex C-serum on Aspergillus niger.

Authors:  K M A Daruliza; K L Lam; K L Yang; J T Priscilla; E Sunderasan; M T Ong
Journal:  Eur Rev Med Pharmacol Sci       Date:  2011-09       Impact factor: 3.507

3.  A mild, rapid, and efficient method of lipid extraction for use in determining vitamin E/lipid ratios.

Authors:  G W Burton; A Webb; K U Ingold
Journal:  Lipids       Date:  1985-01       Impact factor: 1.880

Review 4.  Clinical epidemiology and pharmacology of CYP2D6 inhibition related to breast cancer outcomes.

Authors:  Deirdre P Cronin-Fenton; Timothy L Lash
Journal:  Expert Rev Clin Pharmacol       Date:  2011-05       Impact factor: 5.045

Review 5.  Primary liver cancer: worldwide incidence and trends.

Authors:  F Xavier Bosch; Josepa Ribes; Mireia Díaz; Ramon Cléries
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 6.  Allergenic proteins of natural rubber latex.

Authors:  H Y Yeang; Siti Arija M Arif; Faridah Yusof; E Sunderasan
Journal:  Methods       Date:  2002-05       Impact factor: 3.608

Review 7.  Cytochrome P450 pharmacogenetics and cancer.

Authors:  C Rodriguez-Antona; M Ingelman-Sundberg
Journal:  Oncogene       Date:  2006-03-13       Impact factor: 9.867

Review 8.  Cytochrome P450 enzymes: novel options for cancer therapeutics.

Authors:  Morag C E McFadyen; William T Melvin; Graeme I Murray
Journal:  Mol Cancer Ther       Date:  2004-03       Impact factor: 6.261

9.  Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.

Authors:  Walter M A Westerink; Willem G E J Schoonen
Journal:  Toxicol In Vitro       Date:  2007-06-08       Impact factor: 3.500

10.  Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra.

Authors:  Ramzi A Mothana; Ulrike Lindequist; Renate Gruenert; Patrick J Bednarski
Journal:  BMC Complement Altern Med       Date:  2009-03-25       Impact factor: 3.659

View more
  2 in total

Review 1.  PAQR3: a novel tumor suppressor gene.

Authors:  Xin Yu; Zheng Li; Matthew Tv Chan; William Ka Kei Wu
Journal:  Am J Cancer Res       Date:  2015-08-15       Impact factor: 6.166

2.  miR-454 functions as an oncogene by inhibiting CHD5 in hepatocellular carcinoma.

Authors:  Lei Yu; Xuejun Gong; Lei Sun; Hong Yao; Baoling Lu; Liying Zhu
Journal:  Oncotarget       Date:  2015-11-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.